Chair and Co-founder of VVI, Infectious Disease Specialist, Vienna Vaccine Safety Initiative, GERMANY
Barbara A. Rath, MD PhD HDR is a board-certified pediatrician and infectious disease specialist with 20 years experience in clinical trials, public health, and virology in the US, Latin America and Europe. Dr. Rath is honorary professor at the University of Nottingham School of Medicine, UK, Research Director at the University of Bourgogne-Franche-Comté, France, and board member with the International Society for Influenza and Other Respiratory Viruses (ISIRV). 

She received her medical school education in Germany, the United States and Spain, and her doctoral degrees and habilitation from the University of Basel, Switzerland and the University of Bourgogne-Franche-Comté in France. In addition to a post-doctoral fellowship at the Stanford Department of Medicine, Division of Infectious Diseases & Geographic Medicine, she received pediatric residency and infectious disease subspecialty training at Duke and Tulane Universities, USA. In 2018, she completed the Global Pediatrics Leadership Program at Harvard University Medical School. Recent research focuses on vaccine safety/communication and the quest for a personalized approach to managing acute infections in children. In collaboration with the Robert Koch Institute in Germany, she developed innovative real-time surveillance and quality improvement programs for the monitoring of acute infections with epi/pandemic potential.

Dr. Rath is co-founder and chair of the Vienna Vaccine Safety Initiative (www.vi-vi.org), an international think tank and non-profit-organization focused on new avenues for the individualized treatment, communication, and prevention of infectious diseases. The Vienna Vaccine Safety Initiative Think Tank consists of experts in risk analysis, global health, medical anthropology, epidemiology, population science, health policy, bioethics, and regulatory science. The Vienna Vaccine Safety Initiative is a founding member of the International Association of Innovation Professionals and an institutional member of the European Forum for Good Clinical Practice.